Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection

World Journal of Gastroenterology : WJG
Yi-Chun ChenYen-Chun Chen

Abstract

To investigate the risk of end-stage renal disease (ESRD) in hepatitis B virus (HBV)-infected patients with chronic kidney disease (CKD) with and without nucleos(t)ide analogue (NA) therapy. This nationwide cohort study included 103444 Taiwanese CKD adults without hepatitis C virus infection from the Taiwan Longitudinal Health Insurance Database 2005 between 1997 and 2012. We identified 2916 CKD patients who acquired HBV infection and did not receive NAs (untreated cohort), and they were propensity-matched 1:4 with 11664 uninfected counterparts. We also identified 442 CKD patients who acquired HBV infection and received NAs (treated cohort), and they were propensity-matched 1:3 with 1326 untreated counterparts. The association between HBV infection, NA use, and ESRD was analyzed using competing risk analysis. Multivariable Cox regression analysis showed a 1.67-fold higher risk (P < 0.0001) of ESRD in the untreated cohort (16-year cumulative incidence, 10.1%) than in the matched uninfected cohort (16-year cumulative incidence, 6.6%), which was independent of cirrhosis or diabetes. The treated cohort (16-year cumulative incidence, 2.2%) had an 87% lower ESRD risk (P < 0.0001) compared with the matched untreated cohort (16-year cu...Continue Reading

References

May 23, 1991·The New England Journal of Medicine·K N LaiF M Lai
Apr 16, 1998·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·X Y HeM Y Guo
Nov 7, 1998·BMJ : British Medical Journal·D G Altman
Aug 10, 2005·Journal of Hepatology·Patrice CacoubPhilippe Halfon
Sep 17, 2005·Kidney International·Sydney TangKar Neng Lai
Apr 6, 2006·World Journal of Gastroenterology : WJG·Cun-Liang DengMing-Yong Wang
Dec 23, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hsin-Wei KuoChun-Yuh Yang
Oct 4, 2008·The New England Journal of Medicine·Jules L Dienstag
Apr 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marion G Peters
Feb 6, 2010·World Journal of Gastroenterology : WJG·Yu ZhangFeng-Yu Wang
Apr 20, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jia-Jung LeeShang-Jyh Hwang
May 13, 2010·Current Hepatitis Reports·Tak Mao Chan
Aug 17, 2010·Postgraduate Medical Journal·Elias C ChackoJoseph M Pappachan
Jun 28, 2011·Journal of Hepatology·Stefan MaussEva Herrmann
Aug 4, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Morgan E GramsMark J Sarnak
Jun 21, 2013·Kidney International·Chrysoula L PipiliEvangelos C Cholongitas
Aug 6, 2013·Journal of Viral Hepatitis·G S CookeN Ford
Apr 2, 2014·Nature Reviews. Gastroenterology & Hepatology·Heather Patton, Tram T Tran

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

SAS

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.